Bristol-Myers Squibb and Syngene International, a CRO based in India, have announced a five-year extension of their drug discovery and development collaboration in India. Financial terms have not been disclosed.
Malaysian Bio-XCell and Agila Biotech signed a $34.4 million Build-and-Lease Agreement for the establishment of a customized biotech facility located in the Bio-XCell biotechnology park and ecosystem in Nusajaya, Malaysia.
Biocon, a biotechnology company based in India, has formed a strategic collaboration with Mylan, a global pharmaceutical company, for for the global development and commercialization of generic versions of its three insulin analog products.
Biocon, an Asia-based biotech, has opened the doors of its Integrated Research and Development Centre, Biocon Research Centre (BRC) in India, aimed at pursuing world class research on biologics that will address unmet medical needs.